Stay Informed
Stories

How much do you know about Pfizer?

November 14, 2023

"*" indicates required fields

Pfizer redefines the limits of scientific discovery every day, applying over 170 years of life-changing innovations to build a brighter and better future.

The company’s purpose—breakthroughs that change patients' lives—fuels everything it does. The company’s dedicated colleagues around the world continue to live this purpose every day.

As a result of our commitment to patients and innovation, in 2022 more than 1.3 billion patients around the world were treated with Pfizer’s medicines and vaccines.* The company also made significant strides in strengthening its R&D pipeline and deploying capital into growth-focused business development to access external science. Pfizer continues to take bold steps to position the company for long-term growth potential.

Take this quiz to test your knowledge about Pfizer’s purpose, values, environmental, social, and governance (ESG) priorities and efforts the company has been making to deliver meaningful value for patients, investors and all stakeholders.

Who is the newest member of Pfizer’s executive leadership team?*
What are Pfizer’s core values?*
Pfizer is listed among the Top 10 on Fortune’s World’s Most Admired Companies for 2023.*
Pfizer’s ESG strategy includes six priority areas where the company sees opportunities to create a meaningful impact over the next decade. Which of the following are among the six priorities?*
Pfizer is committed to its ongoing legacy of manufacturing excellence. How many manufacturing sites does the company have worldwide?*
Pfizer completed several acquisitions in 2022, which have further strengthened both the company’s pipeline and current portfolio of innovative offerings for patients. Which company did Pfizer acquire?*

* The patients treated metric is calculated from Pfizer and third-party datasets. Figures may be limited given the coverage provided by external sources (e.g., calendar duration, geographic and product coverage). Numbers are estimates and in some cases use global volume, daily dosage and number of treatment days to facilitate calculations. Methodologies to calculate estimates may vary by product type given the nature of the product and available data. Patients taking multiple Pfizer products may be counted as multiple patients towards total. Numbers include estimated patient counts from U.S. Patient Assistance Programs, ex-U.S. access & affordability programs, product donations and Global Commercial Access Partnerships (this does not include An Accord for a Healthier World). Historical estimates may periodically be subject to revision due to restatements in the underlying data source.

Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website at www.sec.gov.